Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
The company has demonstrated that its proprietary Poly(Catechol-Styrene) (PCS) polymer can induce mineralization of dentin via amorphous calcium phosphate deposition for treatment of sensitive teeth and has developed non‑toxic PCS-based dental and biomedical adhesives for wet environments, but there is no evidence of formal IND‑enabled or clinical-stage therapeutic trials yet.[2][4]
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Mussel Polymers.